Admassie E, Melese T, M. W., & Hailu W, S. B. et al. (2013). Extent of poly-pharmacy, occurrence and associated factors of drug-drug interaction and potential adverse drug reactions in Gondar Teaching Referral Hospital. Journal of Advanced Pharmaceutical Technology & Research, 4(4), 183–189. https://doi.org/10.4103/2231-4040.121412
Alessandra B., Natália M., Fernando A., Rogério B. (2014). Identifying potential drug interactions in chronic kidney disease patients. J Bras Nefrol, 36(1), 26-34. DOI: 10.5935/0101-2800.20140006
Begg CB, M. M. (1994). Operating Characteristics of a Rank Correlation Test for Publication Bias. Biometrics, 50(4), 1088.
Behailu Terefe Tesfay, Teshale Ayele Mega, T. M. K. et al. (2017). Human Immunodeficiency Virus Infected Patients on Highly Active Anti-Retroviral Therapy. Indo American Journal of Pharmaceutical Research, 7(08).
Berha AB, S. N. et al. (2018). Evaluation of drug prescription pattern using world health organization prescribing indicators in Tikur Anbessa Specialized Hospital: a cross–sectional study. Journal of Drug Delivery and Therapeutics, 8(1), 74–78.
Berha AB, S. N. et al. (2018). Evaluation of drug prescription pattern using world health organization prescribing indicators in Tikur Anbessa Specialized Hospital: a cross–sectional study. Journal of Drug Delivery and Therapeutics, 8(1), 74–78.
Bhagavathula, A. S., B, A., T, H., A, Y., & G, Y. (2014). Prevalence of potential drug-drug interactions among internal ward in University of Gondar Teaching Hospital, Ethiopia medicine. Asian Pac J Trop Biomed, 4(1), 204–208. https://doi.org/10.12980/APJTB.4.2014C1172
Bjornsson T, Callaghan J, Einolf H, et al. (2003). Pharmaceutical Research and Manufacturers of America (PhRMA) Drug Metabolism/Clinical Pharmacology Technical Working Group; FDA Center for Drug Evaluation and Research (CDER). The conduct of in vitro and in vivo drug-drug interaction studies: PhRMAperspe. Drug Met Dispos. 31(7), 815–832.
Bolhuis MS, Panday PN, Pranger AD, et al. (2011). Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and beta-lactams. Pharmaceutics, 3(4), 865–913.
D. Miller, R. El-Kholi, J. J. Faragon, and T. P. L. (2007). Prevalence and risk factors for clinically significant drug interactions with antiretroviral therapy. Pharmacotherapy, 27(10), 1379–1386.
Chelkeba L., Alemseged F., B. W. (2013). Assessment of potential drug-drug interactions among outpatients receiving cardiovascular medications at Jimma University specialized hospital, South West Ethiopia. Int J Basic ClinPharmacol, 2(2), 144–152.
Diksis N, Melaku T, Assefa D, T. A. et al. (2019). Potential drug – drug interactions and associated factors among hospitalized cardiac patients at Jimma University Medical Center, Southwest Ethiopia. SAGE Open Med, 7, 1–9. https://doi.org/10.1177/2050312119857353
Egger M, Davey Smith G, Schneider M, M. C. (1997). Bias in Meta-Analysis Detected by a Simple, Graphical Test. BMJ (Clinical Research Ed), 315(7109).
Gebretsadik, Z., Gebrehans, M., Getnet, D., Gebrie, D., Alema, T., & Belay, Y. B. (2017). Assessment of Drug-Drug Interaction in Ayder Comprehensive Specialized Hospital, Mekelle, Northern Ethiopia : A Retrospective Study. BioMed Research Internationa.
Gallelli L., Antonio S., Caterina P., Laura M., Orietta S., Aida S., Francesca M., Emilio R., Santo G., Giovambattista D. (2017). Adverse Drug Reactions Related to Drug Administration in Hospitalized Patients. Curr Drug Saf, 12(3), 171-177. DOI: 10.2174/1574886312666170616090640
Getachew, H., Assen, M., Dula, F., & Bhagavathula, A. S. (2016). Asian Paci fi c Journal of Tropical Biomedicine. Asian Pacific Journal of Tropical Biomedicine, 6(6), 534–538. https://doi.org/10.1016/j.apjtb.2016.04.002
Gunasekaran, T., Dejene, Natsanet, V. V. S., & Dhanaraju, M. D. et al. (2016). Occurrence of drug – drug interactions in Adama Referral Hospital, Adama city, Ethiopia. Journal of Drug Assessment, 4, 19–23. https://doi.org/10.3109/21556660.2015.1067218
Haftay Berhane Mezgebe and Kalid S. (2015). Prevalence of potenial drug-drug interactions among psychitric patients in Ayder referral hospital, Mekelle, Tigray, Ethiopia. Journal of Scientific and Innovative Research, 4(2), 71-75
Heininger-Rothbucher D, Bischinger S, Ulmer H, Pechlaner C, Speer G, W. C. (2001). Incidence and risk of potential adverse drug interactions in the emergency room. Resuscitation, 49, 283–288.
Higgins JP and Julian PT.(2002). Quantifying heterogeneity in a meta-analysis. Statistics in medicine, 21(11).
Janković SM, Pejčić AV, Milosavljevic MN, et al. (2018). Risk factors for potential drug-drug interactions in intensive care unit patients. J Crit Care, 43, 1–6.
Kibrom, S., Tilahun, Z., &Huluka, S. A. et al. (2018). Potential drug-drug interactions among adult patients admitted to medical wards at a tertiary teaching hospital in Ethiopia. Journal of Drug Delivery & Therapeutics, 8(5), 348–354.
Ko Y, Malone DC, Skrepnek GH, Armstrong EP, Murphy JE, Abarca J, Rehfeld RA, Reel SJ, W. R. (2008). Prescribers’ knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers. Drug Saf, 31, 525–536.
Kohler GI, Bode-Boger SM, Busse R, Hoopmann M, Welte T, B. R. (2000). Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J ClinPharmacolTher, 38, 504–513.
Kothari N, G. (2014). Potential Drug-Drug Interactions among Medications Prescribed to Hypertensive Patients. J ClinDisgn Res, 8(11), 1–4.
Laird N. and DerSimonian R. (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
Liberati, A. et al. (2009). The PRISMA Statement for Reporting Systematic Reviews and MetaAnalyses of Studies That Evaluate Health Care Interventions : Explanation and Elaboration. 6 (7).
Mezgebe, H. B., &Seid, K. (2015). Prevalence of potenial drug-drug interactions among psychitric patients in Ayder referral hospital, Mekelle. Journal of Scientific and Innovative Research, 4(2), 71–75.
Mozayani A, R. L. (2004). Handbook of Drug Interactions: A Clinical and Forensic Guide. 1st ed. Totowa, NJ. Humana Press.
Nabovati E., Vakili-Arki H., Taherzadeh Z., Reza Hasibian M., A.-H., &Eslami A., et al. (2014). Drug-drug interactions in inpatient and outpatient settings in Iran: a systematic review of the literature. DARU Journal of Pharmaceutical Sciences, 22(52).
Nasuhara Y., Sakushima K., Endoh A., et al. (2015). Physicians’ responses to computerized drug interaction alerts with password overrides. BMC Med Inform Decis Mak ,15, 74.
Obreli-Neto PR, Nobili A, de Oliveira Baldoni A, et al. (2012). Adverse drug reactions caused by drug–drug interactions in elderly outpatients: a prospective cohort study. Euro J ClinPharmacol, 68(12), 1667–1676.
Palatini P, De Martin S. (2016). Pharmacokinetic drug interactions in liver disease: An update. World J Gastroenterol, 22(3), 1260-1278 Available from: URL: http://www.wjgnet.com/1007- 9327/full/v22/ i3/1260.htm DOI: http://dx.doi.org/10.3748/wjg.v22.i3.1260
Qorraj-Bytyqi H, Hoxha R, Krasniqi S, Bahtiri E, K. V. (2012). The incidence and clinical relevance of drug interaction in pediatrics. J PharmacolPharmacother, 3, 304–307.
Romagnoli KM, Nelson SD, Hines L, et al. (2017). Information needs for making clinical recommendations about potential drugdrug interactions: a synthesis of literature review and interviews. BMC Med Inform DecisMak, 17(1), 21.
SisayM. ,Mengistu G., Molla B., A. F. and G. T. et al. (2017). Evaluation of Rational Drug Use Based on World Health Organization Core Drug Use Indicators in Selected Public Hospitals of Eastern Ethiopia : A Cross Sectional Study. BMC Health Services Research, 17(161), 1–9.
Sisay M., Mengistu G., Molla B., A. F. and G. T. et al. (2017). Evaluation of Rational Drug Use Based on World Health Organization Core Drug Use Indicators in Selected Public Hospitals of Eastern Ethiopia : A Cross Sectional Study. BMC Health Services Research, 17(161), 1–9.
Stockley’s, B. K. (2010). Drug Interactions (9th edn). Pharmaceutical Press:London.
TA, Y., Belay, A. Z., Sisay, E. A., & Gebreamlak, Z. B. et al. (2017). Prevalence and Clinical Significance of Potential Drug-Drug Interactions at Ayder Referral Hospital, Northern Ethiopia. J Dev Drugs, 6(3). https://doi.org/10.4172/2329-6631.1000179
Teka F, Teklay G, Ayalew E, T. T. et al. (2016). Potential drug-drug interactions among elderly patients admitted to medical ward of Ayder Referral Hospital, Northern Ethiopia: a cross sectional study. BMC Res Notes, 1(9), 431.
Teklay, G., Shiferaw, N., Legesse, B., & Bekele, M. L. et al. (2014). Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy : a prospective observational study. Thrombosis Journal, 12(1), 1–8. https://doi.org/10.1186/1477-9560-12-20
Tesfaye Z.T., and N. T. (2017). Potential drug – drug interactions in inpatients treated at the Internal Medicine ward of Tikur Anbessa Specialized Hospital. Drug, Healthcare and Patient Safety, 9, 71–76.
Varma MV, Pang KS, Isoherranen N, Z. P. (2015). Dealing with the complex drug-drug interactions: towards mechanistic models. Biopharm Drug Dispos, 36, 71–92.
Wang JK, Herzog NS, Kaushal R, Park C, Mochizuki C, W. S. (2007). Prevention of pediatric medication errors by hospital pharmacists and the potential benefit of computerized physician order entry. Pediatrics, 119.
Wells, G. A., Shea, B., O’Connell, D., Peterson, J., Welch, V., et al. (2011). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. Retrieved from http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
Zwart-van-Rijkom JEF, Uijtendaal EV, Ten Berg MJ, Van Solinge WW, E. A. (2009). Frequency and nature of drug-drug interactions in a Dutch university hospital. Br J ClinPharmacol, 68, 187–193.